Selenium and Human Health: Witnessing a Copernican Revolution?

Journal of Environmental Science and Health - Part C Environmental Carcinogenesis and Ecotoxicology Reviews

Volumn 33, Issue 3, 2015, Pages 328-368

  Jablonska, Ewa ^a   Vinceti, Marco ^b  

^a NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

biochemistry; cancer; epidemiology; human health; selenium

Indexed keywords

ANTIOXIDANTS; BIOCHEMISTRY; DISEASES; EPIDEMIOLOGY; INDUSTRIAL POISONS; PROTEINS; TRACE ELEMENTS;

ADVERSE HEALTH EFFECTS; ANTI-OXIDANT ACTIVITIES; ANTIOXIDANT PROTEINS; BIOCHEMICAL STUDIES; CANCER; ENVIRONMENTAL EXPOSURE; HUMAN HEALTH; SELENIUM-CONTAINING PROTEINS;

SELENIUM;

SELENIUM; SELENOPROTEIN; SELENIUM DERIVATIVE; TRACE ELEMENT;

BIOCHEMICAL ANALYSIS; BIOCHEMICAL COMPOSITION; BIOLOGICAL ACTIVITY; CANCER RISK; DIETARY INTAKE; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGICAL DATA; EVIDENCE BASED PRACTICE; HEALTH HAZARD; HUMAN; NEUROTOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL REQUIREMENT; PROSTATE CANCER; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SKIN CANCER; UPREGULATION;

ENVIRONMENTAL EXPOSURE; HUMANS; SELENIUM; SELENIUM COMPOUNDS; TRACE ELEMENTS;

EID: 84938830880     PISSN: 10590501     EISSN: 15324095     Source Type: Journal    
DOI: 10.1080/10590501.2015.1055163     Document Type: Review

References (256)

1. Vinceti M, Crespi CM, Malagoli C, Del Giovane C, Krogh V. Friend or foe? The current epidemiologic evidence on selenium and human cancer risk. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2013;31:305-341.
2. Clark LC, Combs GFJ, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JLJ, Park HK, Sanders BBJ, Smith CL, Taylor JR. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA. 1996;276:1957-1963.
3. Lobanov AV, Hatfield DL, Gladyshev VN. Reduced reliance on the trace element selenium during evolution of mammals. Genome Biol. 2008;9:R62.
4. Hatfield DL, Tsuji PA, Carlson BA, Gladyshev VN. Selenium and selenocysteine: roles in cancer, health, and development. Trends Biochem Sci. 2014;39:112-120.
5. Cavelaars AE, Kadvan A, Doets EL, Tepsic J, Novakovic R, Dhonukshe-Rutten R, Renkema M, Glibetic M, Bucchini L, Matthys C, Smith R, van't Veer P, de Groot CP, Gurinovic M. Nutri-RecQuest: a web-based search engine on current micronutrient recommendations. Eur J Clin Nutr. 2010;64(Suppl. 2):S43-47.
6. Vinceti M, Wei ET, Malagoli C, Bergomi M, Vivoli G. Adverse health effects of selenium in humans. Rev Environ Health. 2001;16:233-251.
7. Fan AM, Vinceti M. Selenium and its Compounds. In: Harbison RD, Bourgeois MM, Johnson GT (Eds.), Hamilton & Hardy's Industrial Toxicology. Hoboken, NJ: John Wiley & Sons;2015:205-228.
8. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD, 3rd, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL, Jr., Baker LH, Coltman CA, Jr. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009;301:39-51.
9. Klein EA, Thompson IM, Jr., Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, Karp DD, Lieber MM, Walther PJ, Klotz L, Parsons JK, Chin JL, Darke AK, Lippman SM, Goodman GE, Meyskens FL, Jr., Baker LH. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011;306:1549-1556.
10. Kristal AR, Darke AK, Morris JS, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL, Jr., Goodman GE, Minasian LM, Parnes HL, Lippman SM, Klein EA. Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk. J Natl Cancer Inst. 2014;106:djt456.
11. Albanes D, Till C, Klein EA, Goodman PJ, Mondul AM, Weinstein SJ, Taylor PR, Parnes HL, Gaziano JM, Song X, Fleshner NE, Brown PH, Meyskens FL, Jr., Thompson IM. Plasma tocopherols and risk of prostate cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Cancer Prev Res (Phila). 2014;7:886-895.
12. Martinez EE, Darke AK, Tangen CM, Goodman PJ, Fowke JH, Klein EA, Abdulkadir SA. A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Cancer Prev Res (Phila). 2014;7:950-957.
13. Vinceti M, Dennert G, Crespi CM, Zwahlen M, Brinkman M, Zeegers MP, Horneber M, D'Amico R, Del Giovane C. Selenium for preventing cancer. Cochrane Database Syst Rev. 2014;3:CD005195.
14. Vinceti M, Mandrioli J, Borella P, Michalke B, Tsatsakis A, Finkelstein Y. Selenium neurotoxicity in humans: Bridging laboratory and epidemiologic studies. Toxicol Lett. 2014;230:295-303.
15. Shivakoti R, Gupte N, Yang WT, Mwelase N, Kanyama C, Tang AM, Pillay S, Samaneka W, Riviere C, Berendes S, Lama JR, Cardoso SW, Sugandhavesa P, Semba RD, Christian P, Campbell TB, Gupta A, Nwcs, team Ps. Pre-antiretroviral therapy serum selenium concentrations predict WHO stages 3, 4 or death but not virologic failure post-antiretroviral therapy. Nutrients. 2014;6:5061-5078.
16. Sudfeld CR, Aboud S, Kupka R, Mugusi FM, Fawzi WW. Effect of selenium supplementation on HIV-1 RNA detection in breast milk of Tanzanian women. Nutrition. 2014;30:1081-1084.
17. Stone CA, Kawai K, Kupka R, Fawzi WW. Role of selenium in HIV infection. Nutr Rev. 2010;68:671-681.
18. Sheehan HB, Benetucci J, Muzzio E, Redini L, Naveira J, Segura M, Weissenbacher M, Tang AM. High rates of serum selenium deficiency among HIV- and HCV-infected and uninfected drug users in Buenos Aires, Argentina. Public Health Nutr. 2012;15:538-545.
19. Sandstrom PA, Murray J, Folks TM, Diamond AM. Antioxidant defenses influence HIV-1 replication and associated cytopathic effects. Free Radic Biol Med. 1998;24:1485-1491.
20. Kamwesiga J, Mutabazi V, Kayumba J, Tayari JC, Uwimbabazi JC, Batanage G, Uwera G, Baziruwiha M, Ntizimira C, Murebwayire A, Haguma JP, Nyiransabimana J, Nzabandora JB, Nzamwita P, Mukazayire E, Rwanda Selenium Authorship G. Effect of selenium supplementation on CD4+ T-cell recovery, viral suppression and morbidity of HIV-infected patients in Rwanda: a randomized controlled trial. AIDS. 2015;29:1045-1052.
21. Baum MK, Campa A, Lai S, Sales Martinez S, Tsalaile L, Burns P, Farahani M, Li Y, van Widenfelt E, Page JB, Bussmann H, Fawzi WW, Moyo S, Makhema J, Thior I, Essex M, Marlink R. Effect of micronutrient supplementation on disease progression in asymptomatic, antiretroviral-naive, HIV-infected adults in Botswana: a randomized clinical trial. JAMA. 2013;310:2154-2163.
22. Weekley CM, Harris HH. Which form is that? The importance of selenium speciation and metabolism in the prevention and treatment of disease. Chem Soc Rev. 2013;42:8870-8894.
23. Soni MG, Thurmond TS, Miller ER, 3rd, Spriggs T, Bendich A, Omaye ST. Safety of vitamins and minerals: controversies and perspective. Toxicol Sci. 2010;118:348-355.
24. Nogueira CW, Rocha JB. Toxicology and pharmacology of selenium: emphasis on synthetic organoselenium compounds. Arch Toxicol. 2011;85:1313-1359.
25. Rocourt CR, Cheng WH. Selenium supranutrition: are the potential benefits of chemoprevention outweighed by the promotion of diabetes and insulin resistance? Nutrients. 2013;5:1349-13-65.
26. Guallar E, Stranges S, Mulrow C, Appel LJ, Miller ER, 3rd. Enough is enough: stop wasting money on vitamin and mineral supplements. Ann Intern Med. 2013;159:850-851.
27. INCHEM I. Environmental Health Criteria, 58. Selenium. Geneva, Switzerland: World Health Organization; 1987.
28. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science. 1973;179:588-590.
29. Flohe L, Gunzler WA, Schock HH. Glutathione peroxidase: a selenoenzyme. FEBS Lett. 1973;32:132-134.
30. Duffield-Lillico AJ, Slate EH, Reid ME, Turnbull BW, Wilkins PA, Combs GF, Jr., Park HK, Gross EG, Graham GF, Stratton MS, Marshall JR, Clark LC. Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial. J Natl Cancer Inst. 2003;95:1477-1481.
31. Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GFJ, Slate EH, Fischbach LA, Marshall JR, Clark LC. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev. 2002;11:630-639.
32. Duffield-Lillico AJ, Dalkin BL, Reid ME, Turnbull BW, Slate EH, Jacobs ET, Marshall JR, Clark LC. Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int. 2003;91:608-612.
33. Lippman SM, Goodman PJ, Klein EA, Parnes HL, Thompson IM, Jr., Kristal AR, Santella RM, Probstfield JL, Moinpour CM, Albanes D, Taylor PR, Minasian LM, Hoque A, Thomas SM, Crowley JJ, Gaziano JM, Stanford JL, Cook ED, Fleshner NE, Lieber MM, Walther PJ, Khuri FR, Karp DD, Schwartz GG, Ford LG, Coltman CA, Jr. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst. 2005;97:94-102.
34. Lotan Y, Goodman PJ, Youssef RF, Svatek RS, Shariat SF, Tangen CM, Thompson IM, Jr., Klein EA. Evaluation of vitamin E and selenium supplementation for the prevention of bladder cancer in SWOG coordinated SELECT. J Urol. 2012;187:2005-2010.
35. Kryscio RJ, Abner EL, Schmitt FA, Goodman PJ, Mendiondo M, Caban-Holt A, Dennis BC, Mathews M, Klein EA, Crowley JJ. A randomized controlled Alzheimer's disease prevention trial's evolution into an exposure trial: the PREADViSE Trial. J Nutr Health Aging. 2013;17:72-75.
36. Christen WG, Glynn RJ, Gaziano JM, Darke AK, Crowley JJ, Goodman PJ, Lippman SM, Lad TE, Bearden JD, Goodman GE, Minasian LM, Thompson IM, Jr., Blanke CD, Klein EA. Age-related cataract in men in the selenium and vitamin e cancer prevention trial eye endpoints study: a randomized clinical trial. JAMA Ophthalmol. 2015;133:17-24.
37. Waters DJ, Shen S, Kengeri SS, Chiang EC, Combs GF, Jr., Morris JS, Bostwick DG. Prostatic response to supranutritional selenium supplementation: comparison of the target tissue potency of selenomethionine vs. selenium-yeast on markers of prostatic homeostasis. Nutrients. 2012;4:1650-1663.
38. Marshall JR, Tangen CM, Sakr WA, Wood DP, Jr., Berry DL, Klein EA, Lippman SM, Parnes HL, Alberts DS, Jarrard DF, Lee WR, Gaziano JM, Crawford ED, Ely B, Ray M, Davis W, Minasian LM, Thompson IM, Jr. Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. Cancer Prev Res (Phila). 2011;4:1761-1769.
39. Algotar AM, Stratton MS, Ahmann FR, Ranger-Moore J, Nagle RB, Thompson PA, Slate E, Hsu CH, Dalkin BL, Sindhwani P, Holmes MA, Tuckey JA, Graham DL, Parnes HL, Clark LC, Stratton SP. Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer. Prostate. 2013;73:328-335.
40. Karp DD, Lee SJ, Keller SM, Wright GS, Aisner S, Belinsky SA, Johnson DH, Johnston MR, Goodman G, Clamon G, Okawara G, Marks R, Frechette E, McCaskill-Stevens W, Lippman SM, Ruckdeschel J, Khuri FR. Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597. J Clin Oncol. 2013;31:4179-4187.
41. Ramamoorthy V, Rubens M, Saxena A, Shehadeh N. Selenium and vitamin E for Prostate cancer - justifications for the SELECT Study. Asian Pac J Cancer Prev. 2015;16:2619-2627.
42. Galan-Chilet I, Tellez-Plaza M, Guallar E, De Marco G, Lopez-Izquierdo R, Gonzalez-Manzano I, Carmen Tormos M, Martin-Nunez GM, Rojo-Martinez G, Saez GT, Martin-Escudero JC, Redon J, Javier Chaves F. Plasma selenium levels and oxidative stress biomarkers: a gene-environment interaction population-based study. Free Radic Biol Med. 2014;74:229-236.
43. Haldimann M, Venner TY, Zimmerli B. Determination of selenium in the serum of healthy Swiss adults and correlation to dietary intake. J Trace Elem Med Biol. 1996;10:31-45.
44. Karunasinghe N, Han DY, Zhu S, Yu J, Lange K, Duan H, Medhora R, Singh N, Kan J, Alzaher W, Chen B, Ko S, Triggs CM, Ferguson LR. Serum selenium and single-nucleotide polymorphisms in genes for selenoproteins: relationship to markers of oxidative stress in men from Auckland, New Zealand. Genes Nutr. 2012;7:179-190.
45. Rees K, Hartley L, Day C, Flowers N, Clarke A, Stranges S. Selenium supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013;1:CD009671.
46. Vinceti M, Grioni S, Alber D, Consonni D, Malagoli C, Agnoli C, Malavolti M, Pala V, Krogh V, Sieri S. Toenail selenium and risk of type 2 diabetes: the ORDET cohort study. J Trace Elem Med Biol. 2015;29:145-150.
47. Stranges S, Marshall JR, Natarajan R, Donahue RP, Trevisan M, Combs GF, Cappuccio FP, Ceriello A, Reid ME. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med. 2007;147:217-223.
48. Vinceti M, Crespi CM, Bonvicini F, Malagoli C, Ferrante M, Marmiroli S, Stranges S. The need for a reassessment of the safe upper limit of selenium in drinking water. Sci Total Environ. 2013;443:633-642.
49. Orrell RW, Lane RJ, Ross M. Antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2007:CD002829.
50. Maraldi T, Riccio M, Zambonin L, Vinceti M, De Pol A, Hakim G. Low levels of selenium compounds are selectively toxic for a human neuron cell line through ROS/RNS increase and apoptotic process activation. Neurotoxicol. 2011;32:180-187.
51. Estevez AO, Morgan KL, Szewczyk NJ, Gems D, Estevez M. The neurodegenerative effects of selenium are inhibited by FOXO and PINK1/PTEN regulation of insulin/insulin-like growth factor signaling in Caenorhabditis elegans. Neurotoxicol. 2014;41C:28-43.
52. Saint-Amour D, Roy MS, Bastien C, Ayotte P, Dewailly E, Despres C, Gingras S, Muckle G. Alterations of visual evoked potentials in preschool Inuit children exposed to methylmercury and polychlorinated biphenyls from a marine diet. Neurotoxicol. 2006;27:567-578.
53. Yang GQ, Wang SZ, Zhou RH, Sun SZ. Endemic selenium intoxication of humans in China. Am J Clin Nutr. 1983;37:872-881.
54. Fordyce FM. Technical report WC/96/7R. Report of field visit and initial data from investigations into the prediction and remediation of human selenium imbalances in Enshi District, Hubei Province, China 8-16 November 1995. Nottingham, UK: British Geological Survey; 1996.
55. Mokhber N, Namjoo M, Tara F, Boskabadi H, Rayman MP, Ghayour-Mobarhan M, Sahebkar A, Majdi MR, Tavallaie S, Azimi-Nezhad M, Shakeri MT, Nematy M, Oladi M, Mohammadi M, Ferns G. Effect of supplementation with selenium on postpartum depression: a randomized double-blind placebo-controlled trial. J Matern Fetal Neonatal Med. 2011;24:104-108.
56. Gao S, Jin Y, Unverzagt FW, Liang C, Hall KS, Cao J, Ma F, Murrell JR, Cheng Y, Li P, Bian J, Hendrie HC. Selenium level and depressive symptoms in a rural elderly Chinese cohort. BMC Psychiatry. 2012;12:72.
57. Colangelo LA, He K, Whooley MA, Daviglus ML, Morris S, Liu K. Selenium exposure and depressive symptoms: the Coronary Artery Risk Development in Young Adults Trace Element Study. Neurotoxicol. 2014;41:167-174.
58. Ode A, Rylander L, Gustafsson P, Lundh T, Kallen K, Olofsson P, Ivarsson SA, Rignell-Hydbom A. Manganese and selenium concentrations in umbilical cord serum and attention deficit hyperactivity disorder in childhood. Environ Res. 2015;137C:373-381.
59. Fernandes AP, Wallenberg M, Gandin V, Misra S, Tisato F, Marzano C, Rigobello MP, Kumar S, Björnstedt M. Methylselenol formed by spontaneous methylation of selenide is a superior selenium substrate to the thioredoxin and glutaredoxin systems. PloS one. 2012;7:e50727.
60. Bao P, Chen Z, Tai RZ, Shen HM, Martin FL, Zhu YG. Selenite-induced toxicity in cancer cells is mediated by metabolic generation of endogenous selenium nanoparticles. J Proteome Res. 2015;14:1127-1136.
61. Sieja K, Talerczyk M. Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy. Gynecol Oncol. 2004;93:320-327.
62. Muecke R, Micke O, Schomburg L, Glatzel M, Reichl B, Kisters K, Schaefer U, Huebner J, Eich HT, Fakhrian K, Adamietz IA, Buentzel J, German Working Group Trace E, Electrolytes in Oncology A. Multicenter, phase III trial comparing selenium supplementation with observation in gynecologic radiation oncology: follow-up analysis of the survival data 6 years after cessation of randomization. Integr Cancer Ther. 2014;13:463-467.
63. Dennert G, Horneber M. Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients. Cochrane Database Syst Rev. 2006:CD005037.
64. Kenfield SA, Van Blarigan EL, DuPre N, Stampfer MJ, E LG, Chan JM. Selenium supplementation and prostate cancer mortality. J Natl Cancer Inst. 2015;107:360.
65. Keshan Disease Research Group of the Chinese Academy of Medical Sciences. Epidemiologic studies on the etiologic relationship of selenium and Keshan disease. Chin Med J. 1979;92:477-482.
66. Li S, Xiao T, Zheng B. Medical geology of arsenic, selenium and thallium in China. Sci Total Environ. 2012;421-422:31-40.
67. Loscalzo J. Keshan disease, selenium deficiency, and the selenoproteome. N Engl J Med. 2014;370:1756-1760.
68. Lei C, Niu X, Ma X, Wei J. Is selenium deficiency really the cause of Keshan disease? Environ Geochem Health. 2011;33:183-188.
69. Yang G, Chen J, Wen Z, Ge K, Zhu L, Chen X, Chen X. The role of selenium in Keshan disease. Adv Nutr Res. 1984;6:203-231.
70. Peng T, Li Y, Yang Y, Niu C, Morgan-Capner P, Archard LC, Zhang H. Characterization of enterovirus isolates from patients with heart muscle disease in a selenium-deficient area of China. J Clin Microbiol. 2000;38:3538-3543.
71. Beck MA, Levander OA, Handy J. Selenium deficiency and viral infection. J Nutr. 2003;133:1463S-1467S.
72. Keshan Disease Research Group of the Chinese Academy of Medical Sciences. Observations on effect of sodium selenite in prevention of Keshan disease. Chin Med J. 1979;92:471-476.
73. Cheng YY, Qian PC. The effect of selenium-fortified table salt in the prevention of Keshan disease on a population of 1.05 million. Biomed Environ Sci. 1990;3:422-428.
74. Oxford JS. An inhibitor of the particle-associated RNA-dependent RNA polymerase of influenza A and B viruses. J Gen Virol. 1973;18:11-19.
75. Hamzehei M, Ledinko N. Inhibition of influenza A virus replication by rifampicin and selenocystamine. J Med Virol. 1980;6:169-174.
76. Deidda D, Lampis G, Maullu C, Pompei R, Isaia F, Lippolis V, Verani G. Anti-fungal, antibacterial, antiviral and cytotoxic activity of novel thio- and seleno-azoles. Pharmacol Res. 1997;36:193-197.
77. Chudobova D, Cihalova K, Dostalova S, Ruttkay-Nedecky B, Rodrigo MA, Tmejova K, Kopel P, Nejdl L, Kudr J, Gumulec J, Krizkova S, Kynicky J, Kizek R, Adam V. Comparison of the effects of silver phosphate and selenium nanoparticles on Staphylococcus aureus growth reveals potential for selenium particles to prevent infection. FEMS Microbiol Lett. 2014;351:195-201.
78. Shakibaie M, Forootanfar H, Golkari Y, Mohammadi-Khorsand T, Shakibaie MR. Anti-biofilm activity of biogenic selenium nanoparticles and selenium dioxide against clinical isolates of Staphylococcus aureus, Pseudomonas aeruginosa, and Proteus mirabilis. J Trace Elem Med Biol. 2015;29:235-241.
79. Wu ZL, Yin XB, Lin ZQ, Banuelos GS, Yuan LX, Liu Y, Li M. Inhibitory effect of selenium against Penicillium expansum and its possible mechanisms of action. Curr Microbiol. 2014;69:192-201.
80. Sepulveda RT, Zhang J, Watson RR. Selenium supplementation decreases coxsackievirus heart disease during murine AIDS. Cardiovasc Toxicol. 2002;2:53-61.
81. Cermelli C, Vinceti M, Scaltriti E, Bazzani E, Beretti F, Vivoli G, Portolani M. Selenite inhibition of Coxsackie virus B5 replication: implications on the etiology of Keshan disease. J Trace Elem Med Biol. 2002;16:41-46.
82. Constans J, Delmas-Beauvieux MC, Sergeant C, Peuchant E, Pellegrin JL, Pellegrin I, Clerc M, Fleury H, Simonoff M, Leng B, Conri C. One-year antioxidant supplementation with beta-carotene or selenium for patients infected with human immunodeficiency virus: a pilot study. Clin Infect Dis. 1996;23:654-656.
83. Darlow BA, Winterbourn CC, Inder TE, Graham PJ, Harding JE, Weston PJ, Austin NC, Elder DE, Mogridge N, Buss IH, Sluis KB. The effect of selenium supplementation on outcome in very low birth weight infants: a randomized controlled trial. The New Zealand Neonatal Study Group. J Pediatr. 2000;136:473-480.
84. Shaheen SO, Newson RB, Rayman MP, Wong AP, Tumilty MK, Phillips JM, Potts JF, Kelly FJ, White PT, Burney PG. Randomised, double blind, placebo-controlled trial of selenium supplementation in adult asthma. Thorax. 2007;62:483-490.
85. Mao J, Pop VJ, Bath SC, Vader HL, Redman CW, Rayman MP. Effect of low-dose selenium on thyroid autoimmunity and thyroid function in UK pregnant women with mild-to-moderate iodine deficiency. Eur J Nutr. 2015 (in press).
86. van Zuuren EJ, Albusta AY, Fedorowicz Z, Carter B, Pijl H. Selenium supplementation for Hashimoto's thyroiditis: summary of a Cochrane Systematic Review. Eur Thyroid J. 2014;3:25-31.
87. Miller BJ, Murray L, Beckmann MM, Kent T, Macfarlane B. Dietary supplements for preventing postnatal depression. Cochrane Database Syst Rev. 2013;10:CD009104.
88. Canter PH, Wider B, Ernst E. The antioxidant vitamins A, C, E and selenium in the treatment of arthritis: a systematic review of randomized clinical trials. Rheumatology (Oxford). 2007;46:1223-1233.
89. Andrews PJ, Avenell A, Noble DW, Campbell MK, Croal BL, Simpson WG, Vale LD, Battison CG, Jenkinson DJ, Cook JA, Scottish Intensive care Glutamine or seleNium Evaluative Trial Trials G. Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients. BMJ. 2011;342:d1542.
90. Jirong Y, Huiyun P, Zhongzhe Y, Birong D, Weimin L, Ming Y, Yi S. Sodium selenite for treatment of Kashin-Beck disease in children: a systematic review of randomised controlled trials. Osteoarthritis Cartilage. 2012;20:605-613.
91. Ning YJ, Wang X, Ren L, Guo X. Effects of dietary factors on selenium levels of children to prevent Kashin-Beck disease during a high-prevalence period in an endemic area: a cohort study. Biol Trace Elem Res. 2013;153:58-68.
92. Moreno-Reyes R, Suetens C, Mathieu F, Begaux F, Zhu D, Rivera MT, Boelaert M, Neve J, Perlmutter N, Vanderpas J. Kashin-Beck osteoarthropathy in rural Tibet in relation to selenium and iodine status. N Engl J Med. 1998;339:1112-1120.
93. Marcocci C, Kahaly GJ, Krassas GE, Bartalena L, Prummel M, Stahl M, Altea MA, Nardi M, Pitz S, Boboridis K, Sivelli P, von Arx G, Mourits MP, Baldeschi L, Bencivelli W, Wiersinga W, European Group on Graves O. Selenium and the course of mild Graves' orbitopathy. N Engl J Med. 2011;364:1920-1931.
94. Rayman MP, Bath SC, Westaway J, Williams P, Mao J, Vanderlelie JJ, Perkins AV, Redman CW. Selenium status in UK pregnant women and its relationship with hypertensive conditions of pregnancy. Br J Nutr. 2015:1-10.
95. Alhazzani W, Jacobi J, Sindi A, Hartog C, Reinhart K, Kokkoris S, Gerlach H, Andrews P, Drabek T, Manzanares W, Cook DJ, Jaeschke RZ. The effect of selenium therapy on mortality in patients with sepsis syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med. 2013;41:1555-1564.
96. Rech M, To L, Tovbin A, Smoot T, Mlynarek M. Heavy metal in the intensive care unit: a review of current literature on trace element supplementation in critically ill patients. Nutr Clin Pract. 2014;29:78-89.
97. Forceville X. The effect of selenium therapy on mortality in patients with sepsis syndrome: simple selenium supplementation or real (5 H2O).Na2SeO3 pharmacological effect? Crit Care Med. 2013;41:1591-1592.
98. Manzanares W, Langlois PL, Heyland DK. Pharmaconutrition with selenium in critically ill patients: what do we know? Nutr Clin Pract. 2015;30:34-43.
99. Hofbauer LC, Spitzweg C, Magerstadt RA, Heufelder AE. Selenium-induced thyroid dysfunction. Postgrad Med J. 1997;73:103-104.
100. Hawkes WC, Alkan Z. Regulation of redox signaling by selenoproteins. Biol Trace Elem Res. 2010;134:235-251.
101. Bjornstedt M, Kumar S, Bjorkhem L, Spyrou G, Holmgren A. Selenium and the thioredoxin and glutaredoxin systems. Biomed Environ Sci. 1997;10:271-279.
102. Wallenberg M, Olm E, Hebert C, Björnstedt M, Fernandes AP. Selenium compounds are substrates for glutaredoxins: a novel pathway for selenium metabolism and a potential mechanism for selenium-mediated cytotoxicity. Biochem J. 2010;429:85-93.
103. Hatfield DL, Gladyshev VN. How selenium has altered our understanding of the genetic code. Mol Cell Biol. 2002;22:3565-3576.
104. Brigelius-Flohé R, Maiorino M. Glutathione peroxidases. Biochimica et biophysica acta. 2013;1830:3289-3303.
105. Labunskyy VM, Hatfield DL, Gladyshev VN. Selenoproteins: molecular pathways and physiological roles. Physiol Rev. 2014;94:739-777.
106. Arner ES. Focus on mammalian thioredoxin reductases - important selenoproteins with versatile functions. Biochim Biophys Acta. 2009;1790:495-526.
107. Ip C. Lessons from basic research in selenium and cancer prevention. J Nutr. 1998;128:1845-1854.
108. Letavayova L, Vlckova V, Brozmanova J. Selenium: from cancer prevention to DNA damage. Toxicology. 2006;227:1-14.
109. Jablonska E, Gromadzinska J, Sobala W, Reszka E, Wasowicz W. Lung cancer risk associated with selenium status is modified in smoking individuals by Sep15 polymorphism. Eur J Nutr. 2008;47:47-54.
110. Spallholz JE. Free radical generation by selenium compounds and their prooxidant toxicity. Biomed Environ Sci. 1997;10:260-270.
111. Spallholz JE. On the nature of selenium toxicity and carcinostatic activity. Free Radic Biol Med. 1994;17:45-64.
112. Spallholz JE, Palace VP, Reid TW. Methioninase and selenomethionine but not Se-methylselenocysteine generate methylselenol and superoxide in an in vitro chemiluminescent assay: implications for the nutritional carcinostatic activity of selenoamino acids. Biochem Pharmacol. 2004;67:547-554.
113. Shamberger RJ. The genotoxicity of selenium. Mutat Res. 1985;154:29-48.
114. Santos DB, Schiar VP, Ribeiro MC, Schwab RS, Meinerz DF, Allebrandt J, Rocha JB, Nogueira CW, Aschner M, Barbosa NB. Genotoxicity of organoselenium compounds in human leukocytes in vitro. Mutat Res. 2009;676:21-26.
115. Uguz AC, Naziroglu M, Espino J, Bejarano I, Gonzalez D, Rodriguez AB, Pariente JA. Selenium modulates oxidative stress-induced cell apoptosis in human myeloid HL-60 cells through regulation of calcium release and caspase-3 and -9 activities. J Membr Biol. 2009;232:15-23.
116. Ma Q, Fang H, Shang W, Liu L, Xu Z, Ye T, Wang X, Zheng M, Chen Q, Cheng H. Superoxide flashes: early mitochondrial signals for oxidative stress-induced apoptosis. J Biol Chem. 2011;286:27573-27581.
117. Fan C, Chen J, Wang Y, Wong YS, Zhang Y, Zheng W, Cao W, Chen T. Selenocystine potentiates cancer cell apoptosis induced by 5-fluorouracil by triggering reactive oxygen species-mediated DNA damage and inactivation of the ERK pathway. Free Radic Biol Med. 2013;65C:305-316.
118. Redman C, Scott JA, Baines AT, Basye JL, Clark LC, Calley C, Roe D, Payne CM, Nelson MA. Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines. Cancer Lett. 1998;125:103-110.
119. Waters DJ, Shen S, Glickman LT, Cooley DM, Bostwick DG, Qian J, Combs GF, Jr., Morris JS. Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model. Carcinogenesis. 2005;26:1256-1262.
120. Chiang EC, Shen S, Kengeri SS, Xu H, Combs GF, Morris JS, Bostwick DG, Waters DJ. Defining the optimal selenium dose for prostate cancer risk reduction: insights from the U-shaped relationship between selenium status, DNA damage, and apoptosis. Dose Response. 2009;8:285-300.
121. El-Sayed AS. Microbial L-methioninase: production, molecular characterization, and therapeutic applications. Appl Microbiol Biotechnol. 2010;86:445-467.
122. Palace VP, Spallholz JE, Holm J, Wautier K, Evans RE, Baron CL. Metabolism of selenomethionine by rainbow trout (Oncorhynchus mykiss) embryos can generate oxidative stress. Ecotoxicol Environ Safety. 2004;58:17-21.
123. Papp LV, Holmgren A, Khanna KK. Selenium and selenoproteins in health and disease. Antioxidants & Redox Signaling. 2010;12:793-795.
124. Stadtman TC. Selenium biochemistry. Annu Rev Biochem. 1990;59:111-127.
125. Schrauzer GN. The nutritional significance, metabolism and toxicology of selenomethionine. Adv Food Nutr Res. 2003;47:73-112.
126. Rigby MC, Lemly AD, Gerads R. Fish toxicity testing with selenomethionine spiked feed-what's the real question being asked? Environ Sci Process Impacts. 2014;16:511-517.
127. Brown TA, Shrift A. Selenium: toxicity and tolerance in higher plants. Biologic Rev. 2008;57:59-84.
128. Sinha R, Sinha I, Facompre N, Russell S, Somiari RI, Richie JP, Jr., El-Bayoumy K. Selenium-responsive proteins in the sera of selenium-enriched yeast-supplemented healthy African American and Caucasian men. Cancer Epidemiol Biomarkers Prev. 2010;19:2332-2340.
129. Song H, Zhang B, Watson MA, Humphrey PA, Lim H, Milbrandt J. Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis. Oncogene. 2009;28:3307-3319.
130. Trougakos IP, Djeu JY, Gonos ES, Boothman DA. Advances and challenges in basic and translational research on clusterin. Cancer Res. 2009;69:403-406.
131. Song H, Hur I, Park HJ, Nam J, Park GB, Kong KH, Hwang YM, Kim YS, Cho DH, Lee WJ, Hur DY. Selenium inhibits metastasis of murine melanoma cells through the induction of cell cycle arrest and cell death. Immune Netw. 2009;9:236-242.
132. Wallenberg M, Misra S, Bjornstedt M. Selenium cytotoxicity in cancer. Basic Clin Pharmacol Toxicol. 2014;114:377-386.
133. Cemeli E, Marcos R, Anderson D. Genotoxic and antigenotoxic properties of selenium compounds in the in vitro micronucleus assay with human whole blood lymphocytes and TK6 lymphoblastoid cells. ScientificWorldJournal. 2006;6:1202-1210.
134. Monsen ER. Dietary reference intakes for the antioxidant nutrients: vitamin C, vitamin E, selenium, and carotenoids. J Am Dietet Assoc. 2000;100:637-640.
135. Otten JJ, Hellwig JP, Meyers LD. Dietary Reference Intakes: The Essential Guide to Nutrient Requirements. Washington, DC: National Academy Press; 2006.
136. Zeng H, Combs GF, Jr. Selenium as an anticancer nutrient: roles in cell proliferation and tumor cell invasion. J Nutr Biochem. 2008;19:1-7.
137. Olm E, Fernandes AP, Hebert C, Rundlof AK, Larsen EH, Danielsson O, Bjornstedt M. Extracellular thiol-assisted selenium uptake dependent on the x(c)-cystine transporter explains the cancer-specific cytotoxicity of selenite. Proc Natl Acad Sci U S A. 2009;106:11400-11405.
138. Sanmartin C, Plano D, Sharma AK, Palop JA. Selenium compounds, apoptosis and other types of cell death: an overview for cancer therapy. Int J Mol Sci. 2012;13:9649-9672.
139. Zhou J, Huang K, Lei XG. Selenium and diabetes - evidence from animal studies. Free Radic Biol Med. 2013;65:1548-1556.
140. Steinbrenner H. Interference of selenium and selenoproteins with the insulin-regulated carbohydrate and lipid metabolism. Free Radic Biol Med. 2013;65:1538-1547.
141. McClung JP, Roneker CA, Mu W, Lisk DJ, Langlais P, Liu F, Lei XG. Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase. Proc Natl Acad Sci U S A. 2004;101:8852-8857.
142. Wang XD, Vatamaniuk MZ, Wang SK, Roneker CA, Simmons RA, Lei XG. Molecular mechanisms for hyperinsulinaemia induced by overproduction of selenium-dependent glutathione peroxidase-1 in mice. Diabetologia. 2008;51:1515-1524.
143. Goldstein BJ, Mahadev K, Wu X, Zhu L, Motoshima H. Role of insulin-induced reactive oxygen species in the insulin signaling pathway. Antioxid Redox Signal. 2005;7:1021-1031.
144. Labunskyy VM, Lee BC, Handy DE, Loscalzo J, Hatfield DL, Gladyshev VN. Both maximal expression of selenoproteins and selenoprotein deficiency can promote development of type 2 diabetes-like phenotype in mice. Antioxidants & Redox Signaling. 2011;14:2327-2336.
145. Zeng M-S, Li X, Liu Y, Zhao H, Zhou J-C, Li K, Huang J-Q, Sun L-H, Tang J-Y, Xia X-J, Wang K-N, Lei XG. A high-selenium diet induces insulin resistance in gestating rats and their offspring. Free Radic Biol Med. 2012;52:1335-1342.
146. Mueller AS, Klomann SD, Wolf NM, Schneider S, Schmidt R, Spielmann J, Stangl G, Eder K, Pallauf J. Redox regulation of protein tyrosine phosphatase 1B by manipulation of dietary selenium affects the triglyceride concentration in rat liver. J Nutr. 2008;138:2328-2336.
147. Mueller AS, Bosse AC, Most E, Klomann SD, Schneider S, Pallauf J. Regulation of the insulin antagonistic protein tyrosine phosphatase 1B by dietary Se studied in growing rats. J Nutr Biochem. 2009;20:235-247.
148. Selvaraj N, Sathiyapriya V, Bobby Z, Nandeesha H, Aparna A. Elevated glutathione peroxidase in newly diagnosed hypertension: its relation to insulin resistance. Clin Exp Hypertens. 2013;35:195-199.
149. Jerome-Morais A, Wright ME, Liu R, Yang W, Jackson MI, Combs GF, Jr., Diamond AM. Inverse association between glutathione peroxidase activity and both selenium-binding protein 1 levels and Gleason score in human prostate tissue. Prostate. 2012;72:1006-1012.
150. Banning A, Kipp A, Brigelius-Flohe R. Glutathione peroxidase 2 and its role in cancer. In: Hatfield DL, Berry MJ, Gladyshev VN (Eds.), Selenium: Its Molecular Biology and Role in Human Health. New York: Springer Science+Business Media; 2012:271-282.
151. Yoo MH, Carlson BA, Tsuji PA, Tobe R, Naranjo-Suarez S, Jae Lee J, Davis CD, Gladyshev VN, Hatfield DL. Selenoproteins harboring a split personality in both preventing and promoting cancer. In: Hatfield DL, Berry MJ, Gladyshev VN (Eds.), Selenium: Its Molecular Biology and Role in Human Health. New York: Springer Science+Business Media; 2012:325-334.
152. Saito Y, Hayashi T, Tanaka A, Watanabe Y, Suzuki M, Saito E, Takahashi K. Selenoprotein P in human plasma as an extracellular phospholipid hydroperoxide glutathione peroxidase. Isolation and enzymatic characterization of human selenoprotein p. J Biol Chem. 1999;274:2866-2871.
153. Arteel GE, Mostert V, Oubrahim H, Briviba K, Abel J, Sies H. Protection by selenoprotein P in human plasma against peroxynitrite-mediated oxidation and nitration. Biol Chem. 1998;379:1201-1205.
154. Yang SJ, Hwang SY, Choi HY, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM. Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis. J Clin Endocrinol Metab. 2011;96:E1325-1329.
155. Misu H, Ishikura K, Kurita S, Takeshita Y, Ota T, Saito Y, Takahashi K, Kaneko S, Takamura T. Inverse correlation between serum levels of selenoprotein P and adiponectin in patients with type 2 diabetes. PloS one. 2012;7:e34952.
156. Misu H, Takamura T, Takayama H, Hayashi H, Matsuzawa-Nagata N, Kurita S, Ishikura K, Ando H, Takeshita Y, Ota T, Sakurai M, Yamashita T, Mizukoshi E, Yamashita T, Honda M, Miyamoto K, Kubota T, Kubota N, Kadowaki T, Kim HJ, Lee IK, Minokoshi Y, Saito Y, Takahashi K, Yamada Y, Takakura N, Kaneko S. A liver-derived secretory protein, selenoprotein P, causes insulin resistance. Cell Metab. 2010;12:483-495.
157. Mao J, Teng W. The relationship between selenoprotein P and glucose metabolism in experimental studies. Nutrients. 2013;5:1937-1948.
158. Levander OA, Whanger PD. Deliberations and evaluations of the approaches, endpoints and paradigms for selenium and iodine dietary recommendations. J Nutr. 1996;126:2427S-2434S.
159. Ishikura K, Misu H, Kumazaki M, Takayama H, Matsuzawa-Nagata N, Tajima N, Chikamoto K, Lan F, Ando H, Ota T, Sakurai M, Takeshita Y, Kato K, Fujimura A, Miyamoto K, Saito Y, Kameo S, Okamoto Y, Takuwa Y, Takahashi K, Kidoya H, Takakura N, Kaneko S, Takamura T. Selenoprotein P as a diabetes-associated hepatokine that impairs angiogenesis by inducing VEGF resistance in vascular endothelial cells. Diabetologia. 2014;57:1968-1976.
160. Hurst R, Armah CN, Dainty JR, Hart DJ, Teucher B, Goldson AJ, Broadley MR, Motley AK, Fairweather-Tait SJ. Establishing optimal selenium status: results of a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2010;91: 923-931.
161. Hurst R, Collings R, Harvey LJ, King M, Hooper L, Bouwman J, Gurinovic M, Fairweather-Tait SJ. EURRECA-Estimating Selenium Requirements for Deriving Dietary Reference Values. Crit Rev Food Sci Nutr. 2013;53:1077-1096.
162. Bellinger FP, Raman AV, Rueli RH, Bellinger MT, Dewing AS, Seale LA, Andres MA, Uyehara-Lock JH, White LR, Ross GW, Berry MJ. Changes in selenoprotein P in Substantia Nigra and Putamen in Parkinson's disease. J Parkinsons Dis. 2012;2:115-126.
163. Bellinger FP, He QP, Bellinger MT, Lin Y, Raman AV, White LR, Berry MJ. Association of selenoprotein p with Alzheimer's pathology in human cortex. J Alzheimers Dis. 2008;15:465-472.
164. Choi HY, Hwang SY, Lee CH, Hong HC, Yang SJ, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM. Increased selenoprotein p levels in subjects with visceral obesity and nonalcoholic fatty liver disease. Diabetes Metab J. 2013;37:63-71.
165. Hughes DJ, Fedirko V, Jenab M, Schomburg L, Meplan C, Freisling H, Buenode-Mesquita HB, Hybsier S, Becker NP, Czuban M, Tjonneland A, Outzen M, Boutron-Ruault MC, Racine A, Bastide N, Kuhn T, Kaaks R, Trichopoulos D, Trichopoulou A, Lagiou P, Panico S, Peeters PH, Weiderpass E, Skeie G, Dagrun E, Chirlaque MD, Sanchez MJ, Ardanaz E, Ljuslinder I, Wennberg M, Bradbury KE, Vineis P, Naccarati A, Palli D, Boeing H, Overvad K, Dorronsoro M, Jakszyn P, Cross AJ, Quiros JR, Stepien M, Kong SY, Duarte-Salles T, Riboli E, Hesketh JE. Selenium status is associated with colorectal cancer risk in the European prospective investigation of cancer and nutrition cohort. Int J Cancer. 2015;136:1149-1161.
166. Macallan DC, Sedgwick P. Selenium supplementation and selenoenzyme activity. Clin Sci. 2000;99:579-581.
167. Hafeman DG, Sunde RA, Hoekstra WG. Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat. J Nutr. 1974;104:580-587.
168. Vinceti M, Maraldi T, Bergomi M, Malagoli C. Risk of chronic low-dose selenium overexposure in humans: insights from epidemiology and biochemistry. Rev Environ Health. 2009;24:231-248.
169. Akbulut M, Cakir S. The effects of Se phytotoxicity on the antioxidant systems of leaf tissues in barley (Hordeum vulgare L.) seedlings. Plant Physiol Biochem. 2010;48:160-166.
170. Hasanuzzaman M, Nahar K, Alam MM, Fujita M. Modulation of antioxidant machinery and the methylglyoxal detoxification system in selenium-supplemented Brassica napus seedlings confers tolerance to high temperature stress. Biol Trace Elem Res. 2014;161:297-307.
171. Bronzetti G, Cini M, Andreoli E, Caltavuturo L, Panunzio M, Croce CD. Protective effects of vitamins and selenium compounds in yeast. Mutat Res. 2001;496:105-115.
172. Elia AC, Prearo M, Pacini N, Dorr AJ, Abete MC. Effects of selenium diets on growth, accumulation and antioxidant response in juvenile carp. Ecotoxicol Environ Saf. 2011;74:166-173.
173. Olsvik PA, Amlund H, Saele O, Ellingsen S, Skjaerven KH. Impact of dietary selenium on methylmercury toxicity in juvenile Atlantic cod: a transcriptional survey. Chemosphere. 2014;120C:199-205.
174. Pacini N, Elia AC, Abete MC, Dorr AJ, Brizio P, Gasco L, Righetti M, Prearo M. Antioxidant response versus selenium accumulation in the liver and kidney of the Siberian sturgeon (Acipenser baeri). Chemosphere. 2013;93:2405-2412.
175. Pacini N, Abete MC, Dorr AJ, Prearo M, Natali M, Elia AC. Detoxifying response in juvenile tench fed by selenium diet. Environ Toxicol Pharmacol. 2012;33:46-52.
176. Misra S, Niyogi S. Selenite causes cytotoxicity in rainbow trout (Oncorhynchus mykiss) hepatocytes by inducing oxidative stress. Toxicol In Vitro. 2009;23:1249-1258.
177. Weekley CM, Jeong G, Tierney ME, Hossain F, Maw AM, Shanu A, Harris HH, Witting PK. Selenite-mediated production of superoxide radical anions in A549 cancer cells is accompanied by a selective increase in SOD1 concentration, enhanced apoptosis and Se-Cu bonding. J Biol Inorg Chem. 2014;19:813-828.
178. Akcay T, Dincer Y, Kayali R, Colgar U, Oral E, Cakatay U. Effects of hormone replacement therapy on lipid peroxides and oxidation system in postmenopausal women. J Toxicol Environ Health A. 2000;59:1-5.
179. Beutler E, Matsumoto F, Powars D, Warner J. Increased glutathione peroxidase activity in alpha-thalassemia. Blood. 1977;50:647-655.
180. Chen X, Scholl TO, Leskiw MJ, Donaldson MR, Stein TP. Association of glutathione peroxidase activity with insulin resistance and dietary fat intake during normal pregnancy. J Clin Endocrinol Metab. 2003;88:5963-5968.
181. Eckers JC, Kalen AL, Xiao W, Sarsour EH, Goswami PC. Selenoprotein P inhibits radiation-induced late reactive oxygen species accumulation and normal cell injury. Int J Radiat Oncol Biol Phys. 2013;87:619-625.
182. Eken A, Aydin A, Erdem O, Akay C, Sayal A, Somuncu I. Induced antioxidant activity in hospital staff occupationally exposed to ionizing radiation. Int J Radiat Biol. 2012;88:648-653.
183. Kelner MJ, Bagnell RD, Montoya MA, Lanham KA. Structural organization of the human gastrointestinal glutathione peroxidase (GPX2) promoter and 3'-nontranscribed region: transcriptional response to exogenous redox agents. Gene. 2000;248:109-116.
184. Kim KK, Whitin JC, Sukhova NM, Cohen HJ. Increase in extracellular glutatione peroxidase in plasma and lungs of mice exposed to hyperoxia. Pediatr Res. 1999;46:715-721.
185. Lemaitre D, Vericel E, Polette A, Lagarde M. Effects of fatty acids on human platelet glutathione peroxidase: possible role of oxidative stress. Biochem Pharmacol. 1997;53:479-486.
186. Li RK, Cowan DB, Mickle DA, Weisel RD, Burton GW. Effect of vitamin E on human glutathione peroxidase (GSH-PX1) expression in cardiomyocytes. Free Radic Biol Med. 1996;21:419-426.
187. MacDonald CM. The effects of ethanol on hepatic lipid peroxidation and on the activities of glutathione reductase and peroxidase. FEBS Lett. 1973;35:227-230.
188. Meral A, Tuncel P, Surmen-Gur E, Ozbek R, Ozturk E, Gunay U. Lipid peroxidation and antioxidant status in beta-thalassemia. Pediatr Hematol Oncol. 2000;17:687-693.
189. Ozdem S, Aliciguzel Y, Ozdem SS, Karayalcin U. Effects of propylthiouracil treatment on antioxidant activities in blood of toxic multinodular goiter patients. Pharmacology. 2000;61:31-36.
190. Rahman I, Clerch LB, Massaro D. Rat lung antioxidant enzyme induction by ozone. Am J Physiol. 1991;260:L412-418.
191. Russo C, Olivieri O, Girelli D, Faccini G, Zenari ML, Lombardi S, Corrocher R. Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens. 1998;16:1267-1271.
192. Sahin E, Gumuslu S. Alterations in brain antioxidant status, protein oxidation and lipid peroxidation in response to different stress models. Behav Brain Res. 2004;155:241-248.
193. Sun K, Eriksson SE, Tan Y, Zhang L, Arner ES, Zhang J. Serum thioredoxin reductase levels increase in response to chemically induced acute liver injury. Biochim Biophys Acta. 2014;1840:2105-2111.
194. Zachara BA, Ukleja-Adamowicz M, Nartowicz E, Lecka J. Increased plasma glutathione peroxidase activity in patients with acute myocardial infarction. Med Sci Monit. 2001;7:415-420.
195. Vives Corrons JL, Pujades MA, Colomer D. Increase of enzyme activities following the in vitro peroxidation of normal human red blood cells. Enzyme. 1988;39:1-7.
196. An R, Li Y, Niu X, Yu H. Responses of antioxidant enzymes in catfish exposed to liquid crystals from E-waste. Int J Environ Res Public Health. 2008;5:99-103.
197. Touat-Hamici Z, Legrain Y, Bulteau AL, Chavatte L. Selective upregulation of human selenoproteins in response to oxidative stress. J Biol Chem. 2014;289:14750-14761.
198. Mu W, Tian Y, Piao J, Gu L, Yang X. Studies on comparing the toxicity between sodium selenite and selenomethionine in rats. Wei Sheng Yan Jiu. 2004;33:700-703 (in Chinese).
199. Balogh K, Weber M, Erdelyi M, Mezes M. Investigation of lipid peroxide and glutathione redox status of chicken concerning on high dietary selenium intake. Acta Biol Hung. 2007;58:269-279.
200. Stewart MS, Spallholz JE, Neldner KH, Pence BC. Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis. Free Radic Biol Med. 1999;26:42-48.
201. Olm E, Jonsson-Videsater K, Ribera-Cortada I, Fernandes AP, Eriksson LC, Lehmann S, Rundlof AK, Paul C, Bjornstedt M. Selenite is a potent cytotoxic agent for human primary AML cells. Cancer Lett. 2009;282:116-123.
202. Pacitti D, Wang T, Page MM, Martin SA, Sweetman J, Feldmann J, Secombes CJ. Characterization of cytosolic glutathione peroxidase and phospholipid-hydroperoxide glutathione peroxidase genes in rainbow trout (Oncorhynchus mykiss) and their modulation by in vitro selenium exposure. Aquat Toxicol. 2013;130-131:97-111.
203. Institute of Medicine Food and Nutrition Board. Dietary References Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academy Press; 2000.
204. Joint Food and Agriculture Organization/World Health Organization Expert Consultation on Human Vitamin and Mineral Requirements. Vitamin and Mineral Requirements in Human Nutrition, Second edition. Geneva, Switzerland: World Health Organization and Food and Agriculture Organization of the United Nations; 2004.
205. Burk RF, Jr. Selenium deficiency in search of a disease. Hepatology. 1988;8:421-423.
206. European Food Safety Authority (EFSA), The Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on Dietary Reference Values for selenium. EFSA Journal. 2014;12:1-67.
207. Levander OA. Selenium requirements as discussed in the 1996 joint FAO/IAEA/WHO expert consultation on trace elements in human nutrition. Biomed Environ Sci. 1997;10:214-219.
208. Nordic Nutrition Recommendations 2012 Working Group. Nordic Nutrition Recommendations 2012, Fifth edition. Copenhagen, Denmark: Nordic Council of Ministers; 2014.
209. Traulsen H, Steinbrenner H, Buchczyk DP, Klotz LO, Sies H. Selenoprotein P protects low-density lipoprotein against oxidation. Free Radic Res. 2004;38:123-128.
210. Fairweather-Tait SJ, Bao Y, Broadley MR, Collings R, Ford D, Hesketh JE, Hurst R. Selenium in human health and disease. Antioxid Redox Signal. 2011;14:1337-1383.
211. Xiao W, Zhu Y, Sarsour EH, Kalen AL, Aykin-Burns N, Spitz DR, Goswami PC. Selenoprotein P regulates 1-(4-Chlorophenyl)-benzo-2,5-quinone-induced oxidative stress and toxicity in human keratinocytes. Free Radic Biol Med. 2013;65:70-77.
212. Steinbrenner H, Sies H. Selenium homeostasis and antioxidant selenoproteins in brain: implications for disorders in the central nervous system. Arch Biochem Biophys. 2013;536:152-157.
213. Boehler CJ, Raines AM, Sunde RA. Toxic-selenium and low-selenium transcriptomes in caenorhabditis elegans: toxic selenium up-regulates oxidoreductase and down-regulates cuticle-associated genes. PloS one. 2014;9:e101408.
214. Blessing H, Kraus S, Heindl P, Bal W, Hartwig A. Interaction of selenium compounds with zinc finger proteins involved in DNA repair. Eur J Biochem. 2004;271:3190-3199.
215. Karunasinghe N, Han DY, Zhu S, Duan H, Ko YJ, Yu JF, Triggs CM, Ferguson LR. Effects of supplementation with selenium, as selenized yeast, in a healthy male population from New Zealand. Nutr Cancer. 2013;65:355-366.
216. Reszka E, Jablonska E, Gromadzinska J, Wasowicz W. Relevance of selenoprotein transcripts for selenium status in humans. Genes Nutr. 2012;7:127-137.
217. Brown KM, Pickard K, Nicol F, Beckett GJ, Duthie GG, Arthur JR. Effects of organic and inorganic selenium supplementation on selenoenzyme activity in blood lymphocytes, granulocytes, platelets and erythrocytes. Clin Sci (Lond). 2000;98:593-599.
218. Chandra RK, Hambreaus L, Puri S, Au B, Kutty KM. Immune response of healthy volunteers given supplements of zinc or selenium. FASEB J. 1993:A23.
219. Brätter P, Negretti de Brätter VE. Influence of high dietary intake on the thyroid hormone level in human serum. J Trace Elem Med Biol. 1996;10:163-166.
220. Thorlacius-Ussing O, Flyvbjerg A, Tarp U, Overvad K, Ørskov H. Selenium intake induces growth retardation through reversible growth hormone and irreversible somatomedin C suppression. In: Wendel A (Ed.), Selenium in Biology and Medicine. Berlin, Germany: Springer-Verlag; 1989:126-129.
221. Ammar EM, Couri D. Acute toxicity of sodium selenite and selenomethionine in mice after ICV or IV administration. Neurotoxicol. 1981;2:383-386.
222. Panter KE, Hartley WJ, James LF, Mayland HF, Stegelmeier BL, Kechele PO. Comparative toxicity of selenium from seleno-DL-methionine, sodium selenate, and Astragalus bisulcatus in pigs. Fund Appl Toxicol. 1996;32:217-223.
223. Vinceti M, Rothman KJ, Bergomi M, Borciani N, Serra L, Vivoli G. Excess melanoma incidence in a cohort exposed to high levels of environmental selenium. Cancer Epidemiol Biomarkers Prev. 1998;7:853-856.
224. Vinceti M, Nacci G, Rocchi E, Cassinadri T, Vivoli R, Marchesi C, Bergomi M. Mortality in a population with long-term exposure to inorganic selenium via drinking water. J Clin Epidemiol. 2000;53:1062-1068.
225. Vinceti M, Bonvicini F, Rothman KJ, Vescovi L, Wang F. The relation between amyotrophic lateral sclerosis and inorganic selenium in drinking water: a population-based case-control study. Environ Health. 2010;9:77.
226. Goen T, Schaller B, Jager T, Brau-Dumler C, Schaller KH, Drexler H. Biological monitoring of exposure and effects in workers employed in a selenium-processing plant. Int Arch Occup Environ Health. 2015;88:623-630.
227. National Toxicology Program. Selenium sulfide. Rep Carcinog. 2011;12:376-377.
228. Perchellet JP, Abney NL, Thomas RM, Guislain YL, Perchellet EM. Effects of combined treatments with selenium, glutathione, and vitamin E on glutathione peroxidase activity, ornithine decarboxylase induction, and complete and multistage carcinogenesis in mouse skin. Cancer Res. 1987;47:477-485.
229. Birt DF, Pour PM, Pelling JC. The influence of dietary selenium on colon, pancreas, ans skin tumorigenesis. In: Wendel A (Ed.), Selenium in Biology and Medicine. Berlin, Germany: Springer-Verlag; 1989:297-304.
230. Woutersen RA, Appel MJ, Van Garderen-Hoetmer A. Modulation of pancreatic carcinogenesis by antioxidants. Food Chem Toxicol. 1999;37:981-984.
231. Chen X, Mikhail SS, Ding YW, Yang Gy, Bondoc F, Yang CS. Effects of vitamin E and selenium supplementation on esophageal adenocarcinogenesis in a surgical model with rats. Carcinogenesis. 2000;21:1531-1536.
232. Novoselov SV, Calvisi DF, Labunskyy VM, Factor VM, Carlson BA, Fomenko DE, Moustafa ME, Hatfield DL, Gladyshev VN. Selenoprotein deficiency and high levels of selenium compounds can effectively inhibit hepatocarcinogenesis in transgenic mice. Oncogene. 2005;24:8003-8011.
233. Su YP, Tang JM, Tang Y, Gao HY. Histological and ultrastructural changes induced by selenium in early experimental gastric carcinogenesis. World J Gastroenterol. 2005;11:4457-4460.
234. Lemly AD. Teratogenic effects and monetary cost of selenium poisoning of fish in Lake Sutton, North Carolina. Ecotoxicol Environ Saf. 2014;104:160167.
235. Vinceti M, Stranges S, Sieri S, Grioni S, Malagoli C, Muti P, Berrino F, Krogh V. Association between high selenium intake and subsequent increased risk of type 2 diabetes in an Italian population. Epidemiol. 2009;20:S47.
236. Zwolak I, Zaporowska H. Selenium interactions and toxicity: a review. Cell Biol Toxicol. 2012;28:31-46.
237. Zhang H, Feng X, Chan HM, Larssen T. New insights into traditional health risk assessments of mercury exposure: implications of selenium. Environ Sci Technol. 2014;48:1206-1212.
238. Heinz GH, Hoffman DJ, Klimstra JD, Stebbins KR. A Comparison of the Teratogenicity of Methylmercury and Selenomethionine Injected Into Bird Eggs. Arch Environ Contam Toxicol. 2012;62:519-528.
239. Branco V, Canario J, Lu J, Holmgren A, Carvalho C. Mercury and selenium interaction in vivo: effects on thioredoxin reductase and glutathione peroxidase. Free Radic Biol Med. 2012;52:781-793.
240. Sun HJ, Rathinasabapathi B, Wu B, Luo J, Pu LP, Ma LQ. Arsenic and selenium toxicity and their interactive effects in humans. Environ Int. 2014;69C:148-158.
241. Penglase S, Hamre K, Ellingsen S. Selenium and mercury have a synergistic negative effect on fish reproduction. Aquat Toxicol. 2014;149:16-24.
242. Bjorkman L, Mottet K, Nylander M, Vahter M, Lind B, Friberg L. Selenium concentrations in brain after exposure to methylmercury: relations between the inorganic mercury fraction and selenium. Arch Toxicol. 1995;69:228-234.
243. Borella P, Bargellini A, Medici CI. Chemical form of selenium greatly affects metal uptake and responses by cultured human lymphocytes. Biol Trace Elem Res. 1996;51:43-54.
244. Burk RF, Norsworthy BK, Hill KE, Motley AK, Byrne DW. Effects of chemical form of selenium on plasma biomarkers in a high-dose human supplementation trial. Cancer Epidemiol Biomarkers Prev. 2006;15:804-810.
245. Ravn-Haren G, Bugel S, Krath BN, Hoac T, Stagsted J, Jorgensen K, Bresson JR, Larsen EH, Dragsted LO. A short-term intervention trial with selenate, selenium-enriched yeast and selenium-enriched milk: effects on oxidative defence regulation. Br J Nutr. 2008;99:883-892.
246. Vinceti M, Solovyev N, Mandrioli J, Crespi CM, Bonvicini F, Arcolin E, Georgoulopoulou E, Michalke B. Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite. Neurotoxicol. 2013;38:25-32.
247. Michalke B, Nischwitz V. Review on metal speciation analysis in cerebrospinal fluid-current methods and results: a review. Anal Chim Acta. 2010;682:23-36.
248. Solovyev N, Berthele A, Michalke B. Selenium speciation in paired serum and cerebrospinal fluid samples. Anal Bioanal Chem. 2013;405:1875-1884.
249. Beane Freeman LE, Karagas MR, Baris D, Schwenn M, Johnson AT, Colt JS, Jackson B, Hosain GM, Cantor KP, Silverman DT. Is the inverse association between selenium and bladder cancer due to confounding by smoking? Am J Epidemiol. 2015;181:488-495.
250. Vinceti M, Grill P, Malagoli C, Filippini T, Storani S, Malavolti M, Michalke B. Selenium speciation in human serum and its implications for epidemiologic research: a cross-sectional study. J Trace Elem Med Biol. 2015;31:1-10.
251. Bermingham EN, Bassett SA, Young W, Roy NC, McNabb WC, Cooney JM, Brewster DT, Laing WA, Barnett MP. Post-weaning selenium and folate supplementation affects gene and protein expression and global DNA methylation in mice fed high-fat diets. BMC Med Genomics. 2013;6:7.
252. Xiang N, Zhao R, Zhong W. Sodium selenite induces apoptosis by generation of superoxide via the mitochondrial-dependent pathway in human prostate cancer cells. Cancer Chemother Pharmacol. 2009;63:351-362.
253. Speckmann B, Grune T. Epigenetic effects of selenium and their implications for health. Epigenetics. 2015;10:179-190.
254. Hrdina J, Banning A, Kipp A, Loh G, Blaut M, Brigelius-Flohe R. The gastroin-testinal microbiota affects the selenium status and selenoprotein expression in mice. J Nutr Biochem. 2009;20:638-648.
255. Kasaikina MV, Lobanov AV, Malinouski MY, Lee BC, Seravalli J, Fomenko DE, Turanov AA, Finney L, Vogt S, Park TJ, Miller RA, Hatfield DL, Gladyshev VN. Reduced utilization of selenium by naked mole rats due to a specific defect in GPx1 expression. J Biol Chem. 2011;286:1700517014.
256. Krittaphol W, Wescombe PA, Thomson CD, McDowell A, Tagg JR, Fawcett JP. Metabolism of L-selenomethionine and selenite by probiotic bacteria: in vitro and in vivo studies. Biol Trace Elem Res. 2011;144:1358-1369.